The Houston-based medical device company has developed AuroLase Therapy, a treatment that ablates various solid tumors, and offers research-use-only nanoparticles with specific optical characteristics. Nanospectra Biosciences' therapies utilize a new class of nanoparticles called nanoshells, which convert light into heat and thermally destroy solid tumors. By reducing side effects associated with surgery, radiation, and traditional focal therapies, the company's tissue ablation therapies maximize treatment efficacy.